EarningsQ2 2025 Earnings Report

Rohto Pharmaceutical Co (4527N) Q2 2025 Earnings Report

0 Followers

MX:4527N Q2 2025 EPS Results

Actual EPS$2.96

Consensus EPS$2.84

Beat/MissBeat by +$0.12

One Year Ago EPS$2.21

Actual Revenue$9.36B

Expected Revenue$9.23B

Beat/MissBeat by +$129.11M

YoY Revenue Growth+16.35%

QuarterQ2 2025

Date11/13/2025

TimeTBA

Conference CallThursday, November 13, 2025

MX:4527N Upcoming Earnings

Rohto Pharmaceutical Co's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q2)	3.73 / -	2.96	―
Aug 06, 2026	2026 (Q1)	4.53 / 5.36	5.923	-9.50% (-0.56)
May 13, 2026	2025 (Q4)	3.45 / 3.00	3.113	-3.54% (-0.11)
Feb 12, 2026	2025 (Q3)	5.02 / 5.35	5.923	-9.71% (-0.58)
Nov 13, 2025	2025 (Q2)	2.84 / 2.96	2.213	33.76% (+0.75)
Aug 06, 2025	2025 (Q1)	- / 5.92	4.227	40.10% (+1.70)
May 13, 2025	2024 (Q4)	2.84 / 3.11	2.382	30.69% (+0.73)
Feb 12, 2025	2024 (Q3)	5.58 / 5.92	4.766	24.26% (+1.16)
Nov 13, 2024	2024 (Q2)	3.99 / 2.21	3.74	-40.83% (-1.53)
Aug 07, 2024	2024 (Q1)	4.54 / 4.23	4.531	-6.70% (-0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed